Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€73.77

€73.77

-0.830%
-0.62
-0.830%
€94.38
 
10:51 / Tradegate WKN: A14M2J / Symbol: MDT / Name: Medtronic / Stock / Healthcare Equipment & Supplies / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Medtronic plc Stock

Medtronic plc shows a slight decrease today, losing -€0.620 (-0.830%) compared to yesterday.
We see a rather positive sentiment for Medtronic plc with 11 Buy predictions and 1 Sell predictions.
With a target price of 94 € there is a positive potential of 27.42% for Medtronic plc compared to the current price of 73.77 €.
Our community identified positive and negative aspects for Medtronic plc stock for the coming years. 3 users see the criterium "Worthwhile Investment for the next years" as a plus for the Medtronic plc stock. On the other hand our users think that "General Risks" could be a problem in the future.

Pros and Cons of Medtronic plc in the next few years

Pros
?
B****
?
C******** o* t** e**********
?
S********** s********
Cons
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Medtronic plc vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Medtronic plc -0.830% -2.860% -3.365% -0.040% -0.495% -29.220% -0.148%
Baxter International -0.260% -5.083% -2.614% -4.609% 6.277% -48.004% -43.025%
Dexcom Inc. -1.170% -3.043% 1.791% 16.341% 12.683% 51.180% 413.106%
Dentsply Sirona Inc. 0.140% -4.189% -5.830% -22.688% -11.156% -47.637% -34.502%

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-04-19

Upon first glance at Medtronic's financials, the company appears to be a strong player in the Healthcare Equipment & Supplies sector. Over the years, Medtronic has demonstrated relatively stable financial performance, which is a desirable attribute for a healthcare company. However, more in-depth analysis is needed to better understand the pros and cons of its financial situation.

Revenue Growth: Medtronic's total revenue has experienced consistent growth over the last three years as seen in the yearly income statements. In 2020, the company recorded total revenue of $28.913 billion which increased to $30.117 billion in 2021, and further to $31.686 billion in 2022.

Increasing Gross Profit: Medtronic has seen a rise in its gross profit, from $19.489 billion in 2020 to $19.634 billion in 2021, and eventually $21.541 billion in 2022. This implies that the company is becoming more efficient in its manufacturing and supply chain activities, which is a good sign for potential investors.

Comments

Prediction Buy
Perf. (%) -4.92%
Target price 90.601
Change
Ends at 21.02.25

Medtronic plc (NYSE: MDT) had its price target raised by analysts at Mizuho from $95.00 to $98.00. They now have a "buy" rating on the stock.
Ratings data for MDT provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 4.74%
Target price 90.023
Change
Ends at 22.11.24

Medtronic plc (NYSE: MDT) had its price target lowered by analysts at Morgan Stanley from $104.00 to $98.00. They now have an "overweight" rating on the stock.
Ratings data for MDT provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -2.27%
Target price 94.381
Change
Ends at 23.08.24

Medtronic plc (NYSE: MDT) had its price target raised by analysts at Wells Fargo & Company from $100.00 to $102.00. They now have an "overweight" rating on the stock.
Ratings data for MDT provided by MarketBeat
Show more

News

Medtronic Stock: Buy, Sell, or Hold?: https://g.foolcdn.com/editorial/images/772808/a-doctor-looking-at-a-tablet-with-another-person.jpg
Medtronic Stock: Buy, Sell, or Hold?

Medtronic (NYSE: MDT) is a leading global medical device company with a massive presence that spans more than 150 countries. Its products assist patients with over 70 different health conditions

Got $200? 2 Healthcare Stocks to Buy and Hold Forever.: https://g.foolcdn.com/editorial/images/772266/doctor-and-patient-in-a-hospital-room.jpg
Got $200? 2 Healthcare Stocks to Buy and Hold Forever.

There are plenty of things to buy with $200. But what about investing in a company that can grow your capital for years? Though some people believe they need millions, or at least thousands, to

Better Dividend Stock to Buy Now: Medtronic vs. Walgreens Boots Alliance: https://g.foolcdn.com/editorial/images/771135/two-people-use-devices-at-home-getty.jpg
Better Dividend Stock to Buy Now: Medtronic vs. Walgreens Boots Alliance

If you're an everyday investor looking for stocks that can deliver steadily rising dividend payouts over long periods, the healthcare sector is the right place to begin your search. People get sick